Back

Preferential Invasion Of Differentiated Bladder Carcinoma Cells By Flagellated Group B2 Escherichia Coli

Hogins, J.; Nguyen, J.; Khuwaja, W.; Hall, S.; Fogg, V.; Dong, X.; Zimmern, P. E.; Reitzer, L.

2026-04-17 molecular biology
10.64898/2026.04.16.718932 bioRxiv
Show abstract

Phylogenetic group B2 Escherichia coli is associated with urinary tract infections and other pathologies, but the basis for this phylogenetic skew is not understood. One aspect of urinary tract infections is binding to and entering uroepithelial cells. To test whether a phylogenetic skew exists for cell invasion, we examined invasion of 10 E. coli strains from three phylogenetic groups into CRL2169 and HTB-9 cells, which are derived from grade 1 and grade 2 bladder carcinomas, respectively. The top four strains that invaded CRL2169 were from group B2: three of these strains had more flagella gene transcripts than the other seven strains. The seven strains that invaded HTB-9 were from different phylogenetic groups. For the model uropathogenic group B2 strain UTI89, which expresses pili over flagella, loss of flagella or pili impacted invasion into CRL2169 to similar extents, but loss of pili had a greater effect on invasion into HTB-9 and a murine infection model than loss of flagella. A hyperflagellated variant of a group A strain did not invade either cell line better than the parental strain. Reported transcript differences, which were confirmed experimentally, showed that CRL2169 was more differentiated. The endocytosis stimulator tanshinone enhanced invasion into HTB-9, but not into CRL2169, which suggests differences in endocytic pathways and is consistent with differences in differentiation states. If the initial or recurring event in urinary tract infection is invasion into differentiated urothelial cells, as opposed to tight junctions, then the role of flagella may have been underestimated.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
mBio
750 papers in training set
Top 1%
12.2%
2
Pathogens
53 papers in training set
Top 0.1%
10.0%
3
Infection and Immunity
103 papers in training set
Top 0.1%
10.0%
4
Journal of Virology
456 papers in training set
Top 1.0%
6.3%
5
Scientific Reports
3102 papers in training set
Top 20%
6.2%
6
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 0.7%
4.8%
7
PLOS Pathogens
721 papers in training set
Top 4%
3.6%
50% of probability mass above
8
PLOS ONE
4510 papers in training set
Top 40%
3.5%
9
eLife
5422 papers in training set
Top 32%
2.6%
10
Nature Communications
4913 papers in training set
Top 49%
1.9%
11
Viruses
318 papers in training set
Top 2%
1.9%
12
Frontiers in Immunology
586 papers in training set
Top 4%
1.8%
13
Frontiers in Microbiology
375 papers in training set
Top 5%
1.7%
14
Microorganisms
101 papers in training set
Top 0.8%
1.7%
15
The Journal of Infectious Diseases
182 papers in training set
Top 3%
1.6%
16
mSystems
361 papers in training set
Top 5%
1.6%
17
Molecular Microbiology
66 papers in training set
Top 0.6%
1.5%
18
Biology
43 papers in training set
Top 1%
1.3%
19
Journal of Cell Science
353 papers in training set
Top 1%
1.3%
20
mSphere
281 papers in training set
Top 5%
1.1%
21
International Journal of Molecular Sciences
453 papers in training set
Top 12%
0.9%
22
Cells
232 papers in training set
Top 5%
0.9%
23
Cell Reports
1338 papers in training set
Top 31%
0.9%
24
Microbiology Spectrum
435 papers in training set
Top 5%
0.8%
25
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 2%
0.8%
26
Journal of Bacteriology
190 papers in training set
Top 0.8%
0.7%
27
Biology Open
130 papers in training set
Top 3%
0.7%
28
PLOS Biology
408 papers in training set
Top 22%
0.7%
29
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.7%
30
Frontiers in Molecular Biosciences
100 papers in training set
Top 6%
0.6%